Share this
Neurocrine Partners With Takeda to Address Psychiatric Disorders
June 29, 2020
Neurocrine + Xenon to Develop Treatments for Epilepsy
December 20, 2019
Arena Enters Strategic Partnership With Everest
December 8, 2017
HanAll BioPharma Collaborates with Harbour BioMed
Agreement helps South Korean company develop in China • October 12, 2017
Selecta Biosciences – $74 Million IPO
July 25, 2016
FibroGen Closes Largest Biotech IPO in 12 Years
November 20, 2014
NewLink Genetics Signs $1 Billion Deal with Genentech for Cancer Drug Research and Development
October 22, 2014
Cooley Advises MyoKardia on Collaboration with Sanofi
September 23, 2014
Cooley Advises on Two Independent Billion-Dollar Life Sciences Collaborations
December 16, 2013
Cooley Advises Depomed in its $240 Million Diabetes Drug Sale to PDL BioPharma
October 22, 2013
Cooley Advises FORMA Therapeutics in $200M Strategic Collaboration Deal with Celgene
April 29, 2013
Cooley Represents Molecular Partners in Broad Collaboration with Allergan
September 10, 2012